Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years

Among patients with non-small-cell lung cancer (NSCLC), those with pathological stage I have the best expectation of survival; however, survival is reduced to less than 50% in the long term. At present, it is unclear when patients can be reasonably defined as cured, and if they experience a higher i...

Descripción completa

Detalles Bibliográficos
Autores principales: Pasini, F, Verlato, G, Durante, E, de Manzoni, G, Valduga, F, Accordini, S, Pedrazzani, C, Terzi, A, Pelosi, G
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2003
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377134/
https://www.ncbi.nlm.nih.gov/pubmed/12771977
http://dx.doi.org/10.1038/sj.bjc.6600991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2377134/
https://www.ncbi.nlm.nih.gov/pubmed/12771977
http://dx.doi.org/10.1038/sj.bjc.6600991

Ejemplares similares